In Gastroesophageal Cancers, Better Prevention and Treatments Needed
April 17, 2016 – Debu Tripathy, MD
Medical Illustration: Targeting HER2 in Gastric Cancer
April 15, 2016 – Erin Moore
Cholangiocarcinoma Research is Expanding, But Many Questions Are Still Unanswered
March 28, 2016 – Beth Fand Incollingo
The Next Frontier: The Promise of Immunotherapy in Gastrointestinal Cancers
March 24, 2016 – Arlene Weintraub
Gastrointestinal Stromal Tumors Already Proving to Be Treatable With Targeted Therapies
March 23, 2016 – Heather Millar
Searching on all Fronts: Changing the Outlook for Those With Pancreatic Cancer
March 23, 2016 – Sonya Collins
Right in the Gut: New Clues About Preventing and Treating Gastric Cancer
March 22, 2016 – Erik Ness
An Insight Into Gastric Cancers and Life Without a Stomach
March 22, 2016 – Erik Ness
Changing Lives With Immunotherapy
March 10, 2016 – Mike Hennessy, Sr.
In Gastroesophageal Cancers, Better Prevention and Treatments Needed
April 17, 2016 – Debu Tripathy, MD
Currently Viewing
Medical Illustration: Targeting HER2 in Gastric Cancer
April 15, 2016 – Erin Moore
The Next Frontier: The Promise of Immunotherapy in Gastrointestinal Cancers
March 24, 2016 – Arlene Weintraub
Gastrointestinal Stromal Tumors Already Proving to Be Treatable With Targeted Therapies
March 23, 2016 – Heather Millar
Searching on all Fronts: Changing the Outlook for Those With Pancreatic Cancer
March 23, 2016 – Sonya Collins
Right in the Gut: New Clues About Preventing and Treating Gastric Cancer
March 22, 2016 – Erik Ness
An Insight Into Gastric Cancers and Life Without a Stomach
March 22, 2016 – Erik Ness
Changing Lives With Immunotherapy
March 10, 2016 – Mike Hennessy, Sr.

Medical Illustration: Targeting HER2 in Gastric Cancer

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
BY Erin Moore
PUBLISHED April 15, 2016
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Gastric Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In